TABLE 1.

Antifungal MICs obtained by visual scoring for one QC strain and four clinical strains of Candida species by eight participating laboratories

Antifungal drug	Median IC50 (μg/ml) (range)
	C. parapsilosis ATCC 22019	C. albicans 20533.043	C. albicans 20464.007	C. glabrata 20205.075	C. parapsilosis 20580.070
AMB	1.0 (0.5-2.0)	1.0 (0.5-2.0)	1.0 (0.5-2.0)	1.0 (0.5-2.0)	1.0 (0.5-4.0)
AND	2.0 (0.5-2.0)	0.06 (0.03-0.06)	0.25 (0.12-0.5)	0.06 (0.03-0.06)	2.0 (2.0-4.0)
CSP	1.0 (0.5-2.0)	0.12 (0.06-1.0)	1.0 (1.0-2.0)	0.06 (0.06-0.12)	1.0 (0.5-1.0)
MCF	2.0 (1.0-4.0)	0.06 (0.03-0.12)	0.12 (0.12-0.5)	0.06 (0.06-0.5)	2.0 (1.0-2.0)
PSC	0.25 (0.12-0.5)	1.0 (0.5-2.0)	0.5 (0.25-1.0)	2.0	0.12 (0.06-0.25)
VRC	0.03 (0.03-0.12)	2.0 (1.0-2.0)	2.0	2.0	0.015